AI Product
SimpleScreen CRC
SimpleScreen CRC and pipeline programs built on real-world training data
- Status
- Active
- Category
- Healthcare AI product
- Developer
- Freenome
- Industry
- AI in Healthcare
- Country
- United States
Product Ecosystem Map
How this product connects across company, capabilities, technology, and markets on Brel.
Overview
What this product is, what it does, and who develops it.
SimpleScreen CRC, developed by Freenome in South San Francisco, United States, serves as a dedicated intelligence platform targeting patient biometric interpretation overhead and administrative reporting delays. By executing synthesizing high-dimensional clinical telemetry, the software delivers tangible enhancements in protecting patient privacy while enabling multi-center medical research.
South San Francisco biotechnology company developing multiomics blood tests for early cancer detection
What it does
SimpleScreen CRC and pipeline programs built on real-world training data
Who develops it
Primary care systems, payers, employers, and pharmaceutical partners seeking accessible blood-based cancer screening workflows.
Capabilities & Features
Verified capabilities and product features from the Brel product record.
Capabilities
- AI/ML-enabled multiomics blood tests for colorectal, lung, and broader multi-cancer early detection, including SimpleScre
- SimpleScreen CRC
- pipeline programs built on real-world training data
Technology & Architecture
Technologies, models, and technical structure linked to this product.
Use Cases
Where this product is applied in real operational contexts.
- SimpleScreen CRC and pipeline programs built on real-world training data
Who It Is For
Target users, industries, and deployment context.
Primary care systems, payers, employers, and pharmaceutical partners seeking accessible blood-based cancer screening workflows.
Industries
Industries served
- AI in Healthcare
- Biotechnology
The user profile for SimpleScreen CRC encompasses technical teams, data leaders, and operational specialists in Healthcare who require deterministic performance. Deployment options include air-gapped biomedical research clusters with encrypted enclaves, ensuring robust encryption both in transit and at rest.
Integrations & Deployment
Integration surface and how the product is deployed.
Designed for modern software environments, SimpleScreen CRC interfaces smoothly with standard corporate infrastructure, relational databases, and third-party SaaS endpoints, ensuring zero data lock-in and straightforward integration.
Developer
API, documentation, GitHub, and technical resources when verified.
Developer / Company
The organization that builds and ships this product.
Maintained by Freenome in South San Francisco, United States established in 2014 by Riley Ennis, SimpleScreen CRC delivers automated intelligence capabilities designed specifically for Healthcare environments.
Recent Organizational Milestones: 2014: Freenome founded in South San Francisco; Riley Ennis is co-founder and chief product officer. April 8, 2025: Aaron Elliott, Ph.D., appointed chief executive officer. December 5, 2025: Freenome announced business combination agreement with Perceptive Capital Solutions Corp.
Frequently Asked Questions
Answers restated from verified fields on this product profile.
What is the primary function of SimpleScreen CRC?
SimpleScreen CRC is an AI solution developed by Freenome, designed to deliver shortening experimental therapeutic discovery lifecycles by systematizing synthesizing high-dimensional clinical telemetry.
Who is the organization behind SimpleScreen CRC?
SimpleScreen CRC is built and maintained by Freenome, based in South San Francisco, United States.
What are the core technical features of SimpleScreen CRC?
Documented capabilities include: enabled multiomics blood tests for colorectal, lung, and broader multi; cancer early detection, including SimpleScre SimpleScreen CRC pipeline programs built on real; Freenome's platform applies AI and deep learning across multiomic feature sets trained on large clinical datasets, including real.
What machine learning stack powers SimpleScreen CRC?
SimpleScreen CRC utilizes Machine Learning, Deep Learning, Predictive Analytics, Medical Imaging, Healthcare Analytics, supporting deployment across on-premises hospital data centers behind zero-trust firewalls.
Who is the primary audience for SimpleScreen CRC?
The software is engineered for Primary care systems, payers, employers, and pharmaceutical partners seeking accessible blood-based cancer screening workflows. seeking to mitigate unstructured electronic health record (EHR) data silos.
Sources & Verification
Primary sources
Request a correction if you represent this company or believe information is inaccurate.
Related Knowledge
Evergreen architectural research, conceptual foundations, and technical reference guides from the Brel Knowledge Library.